These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8080533)

  • 21. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
    J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epidemiologic studies and treatment of chronic viral hepatitis C].
    Ouzan D
    Med Trop (Mars); 1994; 54(3 Suppl):18-20. PubMed ID: 7596256
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kiszkis H
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):315-23. PubMed ID: 9017146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alpha in hepatitis C. Dosage, costs and benefits.
    Briggs A; Shiell A
    Pharmacoeconomics; 1996 Sep; 10(3):205-9. PubMed ID: 10163569
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic hepatitis. Differential diagnosis and therapy. 2: Differential hepatitis C diagnosis].
    Schlaak JF; Gerken G
    Fortschr Med; 1997 Jul; 115(20-21):38-9. PubMed ID: 9333584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cryoglobulinemia in chronic hepatitis C. Improvement by alpha-interferon is independent of virus elimination].
    Glück T; Dürk H; Kötter I; Zimmermann C; Saal JG
    Med Klin (Munich); 1995 Dec; 90(12):674-80. PubMed ID: 8583982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of interferons in hepatology.
    Civeira MP
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():33-4. PubMed ID: 8899691
    [No Abstract]   [Full Text] [Related]  

  • 33. Type C chronic hepatitis with the discovery of a small hepatocellular carcinoma 7 years after successful interferon therapy.
    Tomimatsu M; Endo H; Kitazawa M; Iga D; Fujimoto T; Ohkawa S; Kajiyama H; Katagiri S; Harada N; Yamamoto M; Takasaki K
    J Gastroenterol; 2003; 38(4):395-8. PubMed ID: 12743782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Nagral A
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929871
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Babu S
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929872
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Desai HG
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929870
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of viral hepatitis].
    Rambusch EG; Manns MP
    Ther Umsch; 1998 Feb; 55(2):71-6, 78-9. PubMed ID: 9545847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
    Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of the development of two hepatocellular carcinomas and a cholangiocarcinoma with cirrhosis after elimination of serum hepatitis C virus RNA with interferon therapy.
    Nagano K; Fukuda Y; Nakano I; Katano Y; Toyoda H; Ebata M; Morita K; Yokozaki S; Takeuchi M; Hayashi K; Takeda S; Nonami T; Hayakawa T
    Hepatogastroenterology; 2000; 47(35):1436-8. PubMed ID: 11100370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.